ESI-MS: charge states and identity evidence

An ion’s mass-to-charge ratio is not directly the mass of a neutral molecule.

ESI-MS stands for electrospray ionization mass spectrometry. It provides mass information about molecules represented as ions in a sample.

The process has two stages. First, dissolved sample passes through a high-voltage capillary, forming fine charged droplets. As solvent evaporates, progressively smaller droplets ultimately release gas-phase ions. In common positive-mode peptide analysis, protonation supplies charge without requiring backbone damage. An analyzer then separates and detects these ions according to mass-to-charge ratio, m/z.

Electrospray is considered a soft ionization method because it can transfer intact molecular ions into the gas phase without extensive backbone fragmentation. This makes it useful for relatively large, fragile peptides that more energetic ionization conditions could fragment before intact-mass measurement.

One peptide can appear in several charge states, such as singly, doubly and triply charged ions. Deconvolution combines this series to reconstruct neutral molecular mass. That value is compared with the theoretical mass calculated from the sequence, using the monoisotopic or average-mass convention specified for the product.

Molecular-mass testing contributes to identity assessment: is the material consistent with the molecule named on the vial?

A declared sequence implies a theoretical mass. For a conventional unmodified linear chain, calculate it from residue masses plus the terminal contribution of water, adjusting for any declared modifications. Agreement within the specification’s tolerance supports compatibility with that structure. Disagreement can indicate a different sequence, analog, fragment, substituted residue or undeclared modification.

Mass deviations can suggest specific questions rather than only a pass or fail. A whole-residue difference may indicate an insertion or deletion; the difference between two residue masses may suggest substitution. A water-mass difference can be associated with condensation, cyclization or hydrolysis, depending on direction and structure. A protecting-group-sized difference may suggest incomplete deprotection. These are interpretations to investigate, not identities established by the difference alone.

Before opening a received batch, compare the reported mass with the sequence and theoretical mass in its documentation. If the measured value is missing or inconsistent, hold the material aside until clarified. Visual inspection cannot distinguish a correct lyophilizate from an incorrect one.

Traceability is equally important: the certificate batch number must match the physical vial. A result from another batch of the same product does not establish identity for this one.

Intact-mass ESI-MS does not distinguish equal-mass structures, including different residue orders or isobaric residues. Fragmentation or sequence analysis may be needed. It also does not, in this identity application, quantify every nonpeptide component of the vial. Salts, counterions and absorbed water require other determinations, even if some appear as adducts in a spectrum.

HPLC and ESI-MS address different evidence. HPLC separates components and measures their relative chromatographic responses; intact-mass ESI-MS assesses molecular mass after charge-state interpretation. A correct mass can coexist with low chromatographic purity, while a clean HPLC peak can represent the wrong compound. Neither measurement replaces the other, and neither alone measures net peptide content. Also, the most intense spectral peak is an m/z value, not automatically the neutral molecular mass; its charge state must be established.

Charge states, adducts, reference mass, tolerance and processing.